海南葫芦娃药业集团股份有限公司第三届董事会2025年第四次临时会议决议公告

Group 1 - The third board meeting of Hainan Huluwa Pharmaceutical Group Co., Ltd. was held on August 4, 2025, in accordance with relevant regulations [2][4] - The meeting was attended by all six directors, with two participating via remote voting [4][5] - The board approved the appointment of an accounting firm to audit the revised 2023 financial statements due to a change in profit and loss status [6][8] Group 2 - The board proposed to nominate Mr. Wang Qingtang as a non-independent director, pending approval from the shareholders' meeting [9][10] - A temporary shareholders' meeting is scheduled for August 20, 2025, to discuss the approved proposals [10][14] Group 3 - Zhejiang Fuwang Juder Health Development Co., Ltd. holds 57,519,000 shares of the company, representing 14.38% of the total share capital, and has released 5,500,000 shares from pledge [29][30] - After the release of the pledge, the total pledged shares by the shareholder and its concerted parties will be disclosed in accordance with relevant laws and regulations [31]